Literature DB >> 21070903

Comparative study of whole-body MRI and bone scintigraphy for the detection of bone metastases.

E Balliu1, M Boada, I Peláez, J C Vilanova, C Barceló-Vidal, A Rubio, P Galofré, A Castro, S Pedraza.   

Abstract

AIM: To assess and compare the diagnostic accuracy of whole-body magnetic resonance imaging (MRI) and bone scintigraphy in the detection of metastases to bone.
MATERIAL AND METHODS: Forty randomly selected patients with known malignant tumours were prospectively studied using bone scintigraphy and whole-body MRI. Two patients were excluded. Symptoms of bone metastasis were present in 29 (76%) patients and absent in nine (24%). Findings were classified into four categories according to the probability of bone metastasis: (1) negative, (2) probably negative, (3) probably positive, and (4) positive. Diagnostic accuracy was determined according to the area under the receiver operating characteristic (ROC) curve. The definitive diagnosis was reached using other imaging techniques, biopsy, or 12 months clinical follow-up.
RESULTS: Metastases were present in 18 patients. The sensitivity, specificity, and diagnostic accuracy were 94, 90, and 92%, respectively, for whole-body MRI and 72, 75, and 74%, respectively, for bone scintigraphy. Diagnostic accuracy measured by the area under the ROC curve was significantly higher for whole-body MRI (96%) than for bone scintigraphy (77%; p<0.05). Interobserver agreement measured by the kappa index was significantly higher for whole-body MRI (0.895) than for bone scintigraphy (0.524; p<0.05). Whole-body MRI detected lesions in tissues other than bone in 17 (45%) patients.
CONCLUSIONS: Whole-body MRI is more accurate and more objective than bone scintigraphy for the detection of bone metastases. Whole-body MRI can also detect lesions in tissues other than bone.
Copyright © 2010 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21070903     DOI: 10.1016/j.crad.2010.07.002

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  7 in total

1.  Role of whole-body diffusion-weighted MRI in detecting bone metastasis.

Authors:  Riccardo Del Vescovo; Giulia Frauenfelder; Francesco Giurazza; Claudia Lucia Piccolo; Roberto Luigi Cazzato; Rosario Francesco Grasso; Emiliano Schena; Bruno Beomonte Zobel
Journal:  Radiol Med       Date:  2014-03-18       Impact factor: 3.469

2.  Diagnostic accuracy and agreement between whole-body diffusion MRI and bone scintigraphy in detecting bone metastases.

Authors:  A Stecco; M Lombardi; L Leva; M Brambilla; E Negru; S Delli Passeri; A Carriero
Journal:  Radiol Med       Date:  2012-08-08       Impact factor: 3.469

3.  Is bone scintigraphy necessary in the initial surgical staging of chondrosarcoma of bone?

Authors:  Hassan Douis; Steven L James; Robert J Grimer; Mark A Davies
Journal:  Skeletal Radiol       Date:  2011-09-03       Impact factor: 2.199

Review 4.  Advances in Transversal Topics Applicable to the Care of Bladder Cancer Patients in the Real-World Setting.

Authors:  Marga Garrido Siles; Antonio López-Beltran; Paula Pelechano; Ana María García Vicente; Regina Gironés Sarrió; Eva González-Haba Peña; Alfredo Rodríguez Antolín; Almudena Zapatero; José Ángel Arranz; Miguel Ángel Climent
Journal:  Cancers (Basel)       Date:  2022-08-17       Impact factor: 6.575

5.  High uric acid (UA) downregulates bone alkaline phosphatase (BALP) expression through inhibition of its promoter activity.

Authors:  Zhi-Qi Wu; Xiao-Ting Chen; Yan-Yan Xu; Ming-Jie Tian; Hai-Yan Chen; Guo-Ping Zhou; Hua-Guo Xu
Journal:  Oncotarget       Date:  2017-09-20

6.  Whole-body diffusion-weighted imaging with background body signal suppression in the detection of osseous and extra-osseous metastases.

Authors:  Ahmed Abdel Razek; Ahmed Tawfik; Mariam Abdel Rahman; Saleh Teima
Journal:  Pol J Radiol       Date:  2019-11-12

Review 7.  Whole-body MRI: detecting bone metastases from prostate cancer.

Authors:  Katsuyuki Nakanishi; Junichiro Tanaka; Yasuhiro Nakaya; Noboru Maeda; Atsuhiko Sakamoto; Akiko Nakayama; Hiroki Satomura; Mio Sakai; Koji Konishi; Yoshiyuki Yamamoto; Akira Nagahara; Kazuo Nishimura; Satoshi Takenaka; Noriyuki Tomiyama
Journal:  Jpn J Radiol       Date:  2021-10-25       Impact factor: 2.374

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.